CoChat

Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions

Zhang, Nan, Ashizawa, Tetsuo · 2022 · Cells
Cited by 14

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Pentanucleotide expansion diseases constitute a special class of neurodegeneration. The repeat expansions occur in non-coding regions, have likely arisen from Alu elements, and often result in autosomal dominant or recessive phenotypes with underlying cerebellar neuropathology. When transcribed (potentially bidirectionally), the expanded RNA forms complex secondary and tertiary structures that can give rise to RNA-mediated toxicity, including protein sequestration, pentapeptide synthesis, and mRNA dysregulation. Since several of these diseases have recently been discovered, our understanding of their pathological mechanisms is limited, and their therapeutic interventions underexplored. This review aims to highlight new in vitro and in vivo insights into these incurable diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11091567

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 141

  1. Fondon, 2008, Simple sequence repeats: Genetic modulators of brain function and behavior, Trends Neurosci., 31, 328, 10.1016/j.tins.2008.03.006 · DOI
  2. Jansen, 2012, Unstable microsatellite repeats facilitate rapid evolution of coding and regulatory sequences, Genome Dyn., 7, 108, 10.1159/000337121 · DOI
  3. Chintalaphani, 2021, An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics, Acta Neuropathol. Commun., 9, 98, 10.1186/s40478-021-01201-x · DOI · Paper page
  4. Zhang, 2017, RNA toxicity and foci formation in microsatellite expansion diseases, Curr. Opin. Genet. Dev., 44, 17, 10.1016/j.gde.2017.01.005 · DOI · Paper page
  5. Peskett, 2018, A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation, Mol. Cell., 70, 588, 10.1016/j.molcel.2018.04.007 · DOI · Paper page
  6. Rodriguez, 2019, New pathologic mechanisms in nucleotide repeat expansion disorders, Neurobiol. Dis., 130, 104515, 10.1016/j.nbd.2019.104515 · DOI
  7. Chakraborty, 2020, Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis, Proc. Natl. Acad. Sci. USA, 117, 8154, 10.1073/pnas.1917280117 · DOI
  8. Gao, 2019, Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription, Elife, 8, e42988, 10.7554/eLife.42988 · DOI · Paper page
  9. Gerber, 1994, Transcriptional activation modulated by homopolymeric glutamine and proline stretches, Science, 263, 808, 10.1126/science.8303297 · DOI · Paper page
  10. Massey, 2018, The central role of DNA damage and repair in CAG repeat diseases, Dis. Model. Mech., 11, dmm031930, 10.1242/dmm.031930 · DOI
  11. Cleary, 2018, Repeat-associated non-ATG (RAN) translation, J. Biol. Chem., 293, 16127, 10.1074/jbc.R118.003237 · DOI
  12. Manning, 2017, The roles of RNA processing in translating genotype to phenotype, Nat. Rev. Mol. Cell. Biol., 18, 102, 10.1038/nrm.2016.139 · DOI · Paper page
  13. Zu, 2011, Non-ATG-initiated translation directed by microsatellite expansions, Proc. Natl. Acad. Sci. USA, 108, 260, 10.1073/pnas.1013343108 · DOI · Paper page
  14. Brouwer, 2009, Microsatellite repeat instability and neurological disease, Bioessays, 31, 71, 10.1002/bies.080122 · DOI · Paper page
  15. Jain, 2017, RNA phase transitions in repeat expansion disorders, Nature, 546, 243, 10.1038/nature22386 · doi:10.1038/nature22386
  16. Lin, 2003, SCA10 and ATTCT repeat expansion: Clinical features and molecular aspects, Cytogenet. Genome Res., 100, 184, 10.1159/000072853 · DOI
  17. Matsuura, 1999, Mapping of the gene for a novel spinocerebellar ataxia with pure cerebellar signs and epilepsy, Ann. Neurol., 45, 407, 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D · doi:10.1002/1531-8249(199903)45:3<407::aid-ana21>3.0.co;2-d
  18. Matsuura, 2000, Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10, Nat. Genet., 26, 191, 10.1038/79911 · DOI · Paper page
  19. Zu, 1999, Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22, Am. J. Hum. Genet., 64, 594, 10.1086/302247 · DOI
  20. Bushara, K., Bower, M., Liu, J., McFarland, K.N., Landrian, I., Hutter, D., Teive, H.A., Rasmussen, A., Mulligan, C.J., and Ashizawa, T. (2013). Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS ONE, 8. · DOI
  21. Alonso, 2006, Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10, Neurology, 66, 1602, 10.1212/01.wnl.0000216266.30177.bb · doi:10.1212/01.wnl.0000216266.30177.bb
  22. Xia, 2015, Bolivian kindred with combined spinocerebellar ataxia types 2 and 10, Acta Neurol. Scand., 132, 139, 10.1111/ane.12371 · doi:10.1111/ane.12371
  23. Leonardi, 2014, Spinocerebellar ataxia type 10 in Peru: The missing link in the Amerindian origin of the disease, J. Neurol., 261, 1691, 10.1007/s00415-014-7394-8 · DOI
  24. Teive, 2004, Clinical phenotype of Brazilian families with spinocerebellar ataxia 10, Neurology, 63, 1509, 10.1212/01.WNL.0000142109.62056.57 · doi:10.1212/01.wnl.0000142109.62056.57
  25. Bampi, 2019, ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population, Cerebellum, 18, 841, 10.1007/s12311-019-01057-x · doi:10.1007/s12311-019-01057-x
  26. Naito, H., Takahashi, T., Kamada, M., Morino, H., Yoshino, H., Hattori, N., Maruyama, H., Kawakami, H., and Matsumoto, M. (2017). First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS ONE, 12. · DOI
  27. Wang, 2015, Spinocerebellar ataxia type 10 in Chinese Han, Neurol. Genet., 1, e26, 10.1212/NXG.0000000000000026 · doi:10.1212/nxg.0000000000000026
  28. Almeida, T., Alonso, I., Martins, S., Ramos, E.M., Azevedo, L., Ohno, K., Amorim, A., Saraiva-Pereira, M.L., Jardim, L.B., and Matsuura, T. (2009). Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE, 4. · DOI
  29. Matsuura, 2006, Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: Repeat purity as a disease modifier?, Am. J. Hum. Genet., 78, 125, 10.1086/498654 · DOI
  30. McFarland, K.N., Liu, J., Landrian, I., Godiska, R., Shanker, S., Yu, F., Farmerie, W.G., and Ashizawa, T. (2015). SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS ONE, 10. · DOI
  31. McFarland, 2014, Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures, Neurogenetics, 15, 59, 10.1007/s10048-013-0385-6 · doi:10.1007/s10048-013-0385-6
  32. Wright, 2020, Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range, Genet. Med., 22, 2108, 10.1038/s41436-020-0917-z · DOI
  33. Pesovic, 2018, Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells, Front. Genet., 9, 601, 10.3389/fgene.2018.00601 · DOI
  34. Wright, 2020, Interrupting sequence variants and age of onset in Huntington’s disease: Clinical implications and emerging therapies, Lancet Neurol., 19, 930, 10.1016/S1474-4422(20)30343-4 · DOI
  35. Rasmussen, 2001, Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10, Ann. Neurol., 50, 234, 10.1002/ana.1081 · DOI
  36. Diaz, 2019, Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10, Parkinsonism Relat. Disord., 66, 182, 10.1016/j.parkreldis.2019.08.011 · doi:10.1016/j.parkreldis.2019.08.011
  37. Xia, 2013, Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10, J. Neurol. Neurosurg. Psychiatry, 84, 1409, 10.1136/jnnp-2013-305080 · DOI
  38. Grewal, 2002, Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10, Arch. Neurol., 59, 1285, 10.1001/archneur.59.8.1285 · DOI
  39. Ashizawa, 2001, Spinocerebellar ataxia type 10 (SCA10): A disease caused by a novel pentanucleotide repeat expansion, Rinsho Shinkeigaku, 41, 1120
  40. Kurosaki, 2009, Alu-mediated acquisition of unstable ATTCT pentanucleotide repeats in the human ATXN10 gene, Mol. Biol. Evol., 26, 2573, 10.1093/molbev/msp172 · DOI
  41. Potaman, 2003, Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeats, J. Mol. Biol., 326, 1095, 10.1016/S0022-2836(03)00037-8 · DOI
  42. Handa, 2005, The AUUCU repeats responsible for spinocerebellar ataxia type 10 form unusual RNA hairpins, J. Biol. Chem., 280, 29340, 10.1074/jbc.M503495200 · DOI
  43. Guo, 2020, Minidumbbell structures formed by ATTCT pentanucleotide repeats in spinocerebellar ataxia type 10, Nucleic Acids Res., 48, 7557
  44. Wojciechowska, 2011, Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference, Nucleic Acids Res., 39, 3852, 10.1093/nar/gkq1323 · DOI · Paper page
  45. Napierala, 1997, CUG repeats present in myotonin kinase RNA form metastable “slippery” hairpins, J. Biol. Chem., 272, 31079, 10.1074/jbc.272.49.31079 · DOI · Paper page
  46. Reddy, 2013, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures, J. Biol. Chem., 288, 9860, 10.1074/jbc.C113.452532 · DOI · Paper page
  47. Park, 2015, Crystallographic and Computational Analyses of AUUCU Repeating RNA That Causes Spinocerebellar Ataxia Type 10 (SCA10), Biochemistry, 54, 3851, 10.1021/acs.biochem.5b00551 · doi:10.1021/acs.biochem.5b00551
  48. Komar, 2005, Internal ribosome entry sites in cellular mRNAs: Mystery of their existence, J. Biol. Chem., 280, 23425, 10.1074/jbc.R400041200 · DOI · Paper page
  49. Komar, 2011, Cellular IRES-mediated translation: The war of ITAFs in pathophysiological states, Cell Cycle, 10, 229, 10.4161/cc.10.2.14472 · DOI · Paper page
  50. Green, 2017, RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response, Nat. Commun., 8, 2005, 10.1038/s41467-017-02200-0 · DOI · Paper page
  51. Wakamiya, 2006, The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10, Neurology, 67, 607, 10.1212/01.wnl.0000231140.26253.eb · DOI
  52. Sznajder, 2018, Intron retention induced by microsatellite expansions as a disease biomarker, Proc. Natl. Acad. Sci. USA, 115, 4234, 10.1073/pnas.1716617115 · DOI · Paper page
  53. Keren, 2010, Evidence against haploinsuffiency of human ataxin 10 as a cause of spinocerebellar ataxia type 10, Neurogenet., 11, 273, 10.1007/s10048-009-0227-8 · doi:10.1007/s10048-009-0227-8
  54. White, M.C., Gao, R., Xu, W., Mandal, S.M., Lim, J.G., Hazra, T.K., Wakamiya, M., Edwards, S.F., Raskin, S., and Teive, H.A. (2010). Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet., 6. · DOI · Paper page
  55. McFarland, 2012, Transgenic models of spinocerebellar ataxia type 10: Modeling a repeat expansion disorder, Genes, 3, 481, 10.3390/genes3030481 · DOI
  56. White, 2012, Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model, J. Neurosci. Res., 90, 706, 10.1002/jnr.22786 · doi:10.1002/jnr.22786
  57. Bomsztyk, 2004, hnRNP K: One protein multiple processes, Bioessays, 26, 629, 10.1002/bies.20048 · DOI · Paper page
  58. Auweter, 2006, Sequence-specific binding of single-stranded RNA: Is there a code for recognition?, Nucleic Acids Res., 34, 4943, 10.1093/nar/gkl620 · DOI · Paper page
  59. Gallardo, 2016, Aberrant hnRNP K expression: All roads lead to cancer, Cell Cycle, 15, 1552, 10.1080/15384101.2016.1164372 · DOI
  60. Schultz, 2020, Cancer frequency in patients with spinocerebellar ataxia type 10, Parkinsonism Relat. Disord., 76, 1, 10.1016/j.parkreldis.2020.05.032 · doi:10.1016/j.parkreldis.2020.05.032
  61. Cherng, 2011, Expansions, contractions, and fragility of the spinocerebellar ataxia type 10 pentanucleotide repeat in yeast, Proc. Natl. Acad. Sci. USA, 108, 2843, 10.1073/pnas.1009409108 · DOI · Paper page
  62. Liu, 2007, Unstable spinocerebellar ataxia type 10 (ATTCT*(AGAAT) repeats are associated with aberrant replication at the ATX10 locus and replication origin-dependent expansion at an ectopic site in human cells, Mol. Cell. Biol., 27, 7828, 10.1128/MCB.01276-07 · DOI
  63. Hashem, V., Tiwari, A., Bewick, B., Teive, H.A.G., Moscovich, M., Schuele, B., Bushara, K., Bower, M., Rasmussen, A., and Tsai, Y.C. (2020). Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS ONE, 15. · doi:10.1371/journal.pone.0231746
  64. Yang, 2016, Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10, Nat. Commun., 7, 11647, 10.1038/ncomms11647 · DOI
  65. Rzuczek, 2017, Precise small-molecule recognition of a toxic CUG RNA repeat expansion, Nat. Chem. Biol., 13, 188, 10.1038/nchembio.2251 · DOI · Paper page
  66. Lee, 2007, 16q-linked autosomal dominant cerebellar ataxia in a Korean family, Eur. J. Neurol., 14, e16, 10.1111/j.1468-1331.2007.01818.x · doi:10.1111/j.1468-1331.2007.01818.x
  67. Lee, 2012, SCA31 is rare in the Chinese population on Taiwan, Neurobiol. Aging, 33, 426.e23, 10.1016/j.neurobiolaging.2010.10.012 · doi:10.1016/j.neurobiolaging.2010.10.012
  68. Ouyang, 2012, Spinocerebellar ataxia type 31 exists in northeast China, J. Neurol. Sci., 316, 164, 10.1016/j.jns.2012.02.005 · doi:10.1016/j.jns.2012.02.005
  69. Yang, 2018, Analysis of spinocerebellar ataxia type 31 related mutations among patients from mainland China, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 35, 309
  70. Ishikawa, 2011, Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians, Neurol. Aging, 77, 1853
  71. Pedroso, 2015, When should we test patients with familial ataxias for SCA31? A misdiagnosed condition outside Japan?, J. Neurol. Sci., 355, 206, 10.1016/j.jns.2015.05.016 · doi:10.1016/j.jns.2015.05.016
  72. Nakamura, 2017, Natural History of Spinocerebellar Ataxia Type 31: A 4-Year Prospective Study, Cerebellum, 16, 518, 10.1007/s12311-016-0833-6 · DOI
  73. Owada, 2005, A clinical, genetic, and neuropathologic study in a family with 16q-linked ADCA type III, Neurology, 65, 629, 10.1212/01.wnl.0000173065.75680.e2 · DOI
  74. Itaya, 2018, Spinocerebellar Ataxia Type 31 with Blepharospasm, Intern. Med., 57, 1651, 10.2169/internalmedicine.0068-17 · doi:10.2169/internalmedicine.0068-17
  75. Norioka, 2021, Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: Five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction, Cerebellum Ataxias, 8, 11, 10.1186/s40673-021-00134-4 · DOI
  76. Ishikawa, 2010, The chromosome 16q-linked autosomal dominant cerebellar ataxia (16q-ADCA): A newly identified degenerative ataxia in Japan showing peculiar morphological changes of the Purkinje cell: The 50th Anniversary of Japanese Society of Neuropathology, Neuropathology, 30, 490, 10.1111/j.1440-1789.2010.01142.x · doi:10.1111/j.1440-1789.2010.01142.x
  77. Niimi, 2013, Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis, Neuropathology, 33, 600, 10.1111/neup.12032 · DOI
  78. Yoshida, 2014, Distinctive features of degenerating Purkinje cells in spinocerebellar ataxia type 31, Neuropathology, 34, 261, 10.1111/neup.12090 · doi:10.1111/neup.12090
  79. Sato, 2009, Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n, Am. J. Hum. Genet., 85, 544, 10.1016/j.ajhg.2009.09.019 · DOI · Paper page
  80. Ishiguro, 2017, Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31, Neuron, 94, 108, 10.1016/j.neuron.2017.02.046 · DOI · Paper page
  81. Valgardsdottir, 2008, Transcription of Satellite III non-coding RNAs is a general stress response in human cells, Nucleic Acids Res., 36, 423, 10.1093/nar/gkm1056 · DOI · Paper page
  82. Valgardsdottir, 2005, Structural and functional characterization of noncoding repetitive RNAs transcribed in stressed human cells, Mol. Biol. Cell., 16, 2597, 10.1091/mbc.e04-12-1078 · DOI · Paper page
  83. Goenka, 2016, Human satellite-III non-coding RNAs modulate heat-shock-induced transcriptional repression, J. Cell. Sci., 129, 3541, 10.1242/jcs.189803 · DOI
  84. Chiodi, 2004, RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies, Nucleic Acids Res., 32, 4127, 10.1093/nar/gkh759 · DOI
  85. Metz, 2004, A key role for stress-induced satellite III transcripts in the relocalization of splicing factors into nuclear stress granules, J. Cell. Sci., 117, 4551, 10.1242/jcs.01329 · DOI
  86. Ishiguro, 2021, Insight Into Spinocerebellar Ataxia Type 31 (SCA31) From Drosophila Model, Front. Neurosci., 15, 648133, 10.3389/fnins.2021.648133 · DOI
  87. McLoughlin, 2020, Pathogenesis of SCA3 and implications for other polyglutamine diseases, Neurobiol. Dis., 134, 104635, 10.1016/j.nbd.2019.104635 · DOI · Paper page
  88. Kumar, 2014, Transcriptional dysregulation in Huntington’s disease: A failure of adaptive transcriptional homeostasis, Drug Discov. Today, 19, 956, 10.1016/j.drudis.2014.03.016 · DOI · Paper page
  89. Huang, Y.C., Lin, K.F., He, R.Y., Tu, P.H., Koubek, J., Hsu, Y.C., and Huang, J.J. (2013). Inhibition of TDP-43 aggregation by nucleic acid binding. PLoS ONE, 8. · DOI · Paper page
  90. Mann, 2019, RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43, Neuron, 102, 321, 10.1016/j.neuron.2019.01.048 · DOI · Paper page
  91. Shibata, 2021, Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model, Nat. Commun., 12, 236, 10.1038/s41467-020-20487-4 · DOI
  92. Seixas, 2017, A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia, Am. J. Hum. Genet., 101, 87, 10.1016/j.ajhg.2017.06.007 · DOI · Paper page
  93. Stevanin, 2013, New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32, JAMA Neurol., 70, 764, 10.1001/jamaneurol.2013.2311 · DOI
  94. Rabano, 2018, Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37, Brain, 141, 1981, 10.1093/brain/awy137 · DOI · Paper page
  95. Goldowitz, 1997, Cerebellar disorganization characteristic of reeler in scrambler mutant mice despite presence of reelin, J. Neurosci., 17, 8767, 10.1523/JNEUROSCI.17-22-08767.1997 · DOI · Paper page
  96. Sweet, 1996, Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration, Mamm. Genome, 7, 798, 10.1007/s003359900240 · DOI
  97. Lee, 2003, XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response, Mol. Cell. Biol., 23, 7448, 10.1128/MCB.23.21.7448-7459.2003 · DOI · Paper page
  98. Cortese, 2020, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion, Brain, 143, 480, 10.1093/brain/awz418 · DOI · Paper page
  99. Szmulewicz, 2011, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): A review of the clinical features and video-oculographic diagnosis, Ann. N. Y. Acad. Sci., 1233, 139, 10.1111/j.1749-6632.2011.06158.x · DOI · Paper page
  100. Szmulewicz, 2014, Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS, Neurology, 82, 1410, 10.1212/WNL.0000000000000352 · DOI
  101. Sullivan, 2021, Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: Genetic and clinical insights, Curr. Opin. Neurol., 34, 556, 10.1097/WCO.0000000000000961 · DOI
  102. Pelosi, 2018, Peripheral nerves are pathologically small in cerebellar ataxia neuropathy vestibular areflexia syndrome: A controlled ultrasound study, Eur. J. Neurol., 25, 659, 10.1111/ene.13563 · DOI
  103. Reyes-Leiva, D., Aldecoa, I., Gelpi, E., and Rojas-Garcia, R. (2022). Motor neuron involvement expands the neuropathological phenotype of late-onset ataxia in RFC1 mutation (CANVAS). Brain Pathol., e13051. · DOI
  104. Huin, V., Coarelli, G., Guemy, C., Boluda, S., Debs, R., Mochel, F., Stojkovic, T., Grabli, D., Maisonobe, T., and Gaymard, B. (2021). Motor neuron pathology in CANVAS due to RFC1 expansions. Brain, awab449. · DOI
  105. Akcimen, 2019, Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations, Front. Genet., 10, 1219, 10.3389/fgene.2019.01219 · DOI
  106. Scriba, 2020, A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families, Brain, 143, 2904, 10.1093/brain/awaa263 · DOI
  107. Tsuchiya, 2020, RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia, J. Hum. Genet., 65, 1143, 10.1038/s10038-020-0807-x · DOI
  108. Beecroft, 2020, A Maori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele, Brain, 143, 2673, 10.1093/brain/awaa203 · DOI
  109. Lek, 2016, Analysis of protein-coding genetic variation in 60,706 humans, Nature, 536, 285, 10.1038/nature19057 · DOI · Paper page
  110. Loureiro, J.R., Castro, A.F., Figueiredo, A.S., and Silveira, I. (2022). Molecular Mechanisms in Pentanucleotide Repeat Diseases. Cells, 11. · DOI · Paper page
  111. Hesselberth, 2013, Lives that introns lead after splicing, Wires RNA, 4, 677, 10.1002/wrna.1187 · DOI
  112. Hautbergue, 2017, SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits, Nat. Commun., 8, 16063, 10.1038/ncomms16063 · DOI · Paper page
  113. Campuzano, 1997, Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes, Hum. Mol. Genet., 6, 1771, 10.1093/hmg/6.11.1771 · DOI · Paper page
  114. Campuzano, 1996, Friedreich’s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion, Science, 271, 1423, 10.1126/science.271.5254.1423 · DOI · Paper page
  115. Garcia, J.C., and Bustos, R.H. (2018). The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives. Brain Sci., 8. · DOI
  116. Wang, 2018, Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9, Mol. Ther., 26, 2617, 10.1016/j.ymthe.2018.09.003 · DOI
  117. Monteys, 2017, CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo, Mol. Ther., 25, 12, 10.1016/j.ymthe.2016.11.010 · DOI · Paper page
  118. Dastidar, 2018, Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells, Nucleic Acids Res., 46, 8275, 10.1093/nar/gky548 · DOI
  119. Pinto, 2017, Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9, Mol. Cell., 68, 479, 10.1016/j.molcel.2017.09.033 · DOI
  120. Batra, 2017, Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9, Cell, 170, 899, 10.1016/j.cell.2017.07.010 · DOI · Paper page
  121. Zhang, 2020, A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1, Front. Genet., 11, 594576, 10.3389/fgene.2020.594576 · DOI
  122. Andre, 2017, CRISPR/Cas9-Induced (CTGCAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing, Mol. Ther., 25, 24, 10.1016/j.ymthe.2016.10.014 · DOI
  123. Wheeler, 2009, Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA, Science, 325, 336, 10.1126/science.1173110 · DOI · Paper page
  124. Manning, 2017, BNA(NC) Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells, ACS Chem. Biol., 12, 2503, 10.1021/acschembio.7b00416 · DOI
  125. Wheeler, 2012, Targeting nuclear RNA for in vivo correction of myotonic dystrophy, Nature, 488, 111, 10.1038/nature11362 · DOI · Paper page
  126. Jauvin, 2017, Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice, Mol. Ther. Nucleic Acids, 7, 465, 10.1016/j.omtn.2017.05.007 · DOI
  127. McLoughlin, 2018, Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice, Ann. Neurol., 84, 64, 10.1002/ana.25264 · DOI · Paper page
  128. Moore, 2019, Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line, Stem Cell Res., 39, 101504, 10.1016/j.scr.2019.101504 · DOI
  129. Zhang, 2021, DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases, Neurotherapeutics, 18, 1710, 10.1007/s13311-021-01075-w · DOI
  130. Cinesi, 2016, Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase, Nat. Commun., 7, 13272, 10.1038/ncomms13272 · DOI
  131. Ouellet, 2017, Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia, Gene. Ther., 24, 265, 10.1038/gt.2016.89 · DOI
  132. Ikeda, 2020, Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach, Mol. Ther. Methods Clin. Dev., 18, 131, 10.1016/j.omtm.2020.05.024 · DOI
  133. Mosbach, V., Viterbo, D., Descorps-Declere, S., Poggi, L., Vaysse-Zinkhofer, W., and Richard, G.F. (2020). Resection and repair of a Cas9 double-strand break at CTG trinucleotide repeats induces local and extensive chromosomal deletions. PLoS. Genet., 16. · DOI
  134. Rong, 2020, Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs’ Endothelial Corneal Dystrophy, Transl. Vis. Sci. Technol., 9, 47, 10.1167/tvst.9.9.47 · doi:10.1167/tvst.9.9.47
  135. Burstein, 2017, New CRISPR-Cas systems from uncultivated microbes, Nature, 542, 237, 10.1038/nature21059 · DOI · Paper page
  136. Harrington, 2018, Programmed DNA destruction by miniature CRISPR-Cas14 enzymes, Science, 362, 839, 10.1126/science.aav4294 · DOI · Paper page
  137. Pausch, 2020, CRISPR-CasPhi from huge phages is a hypercompact genome editor, Science, 369, 333, 10.1126/science.abb1400 · DOI · Paper page
  138. Wang, 2019, The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells, Adv. Sci., 6, 1901299, 10.1002/advs.201901299 · DOI · Paper page
  139. Zhao, 2018, A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment, Cancer Lett., 431, 171, 10.1016/j.canlet.2018.05.042 · DOI · Paper page
  140. Abbott, 2020, Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza, Cell, 181, 865, 10.1016/j.cell.2020.04.020 · DOI · Paper page
  141. Zhang, 2022, DNAzyme as a rising gene-silencing agent in theranostic settings, Neural Regen. Res., 17, 1989, 10.4103/1673-5374.335157 · DOI

Cited by

Metadata

Authors
Zhang, N., & Ashizawa, T.
Affiliations
Neuroscience Research Program, Department of Neurology, Houston Methodist Research Institute, Weil Cornell Medical College, Houston, TX 77030, USA
Venue
Cells
Publisher
MDPI AG
Published
2022-05-06
Volume
11
Issue
9
Pages
1567
ISSN
2073-4409
Cited by
14
References
10
Language
en
Funders
Forster Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.